跳至主要内容
临床试验/NCT02982200
NCT02982200终止不适用

The MEDINA Study: Medina Embolization Device In Neurovascular Aneurysms Study - A Post Market Clinical Follow-up Study

Medtronic Neurovascular Clinical Affairs3 个研究点 分布在 3 个国家目标入组 15 人开始时间: 2016年12月15日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
15
试验地点
3
主要终点
Complete aneurysm occlusion as defined by the Modified Raymond-Roy Classification (MRRC)

研究概览

简要总结

A global prospective, multi-center, single-arm, post-market clinical follow-up (PMCF) study conducted to assess the performance of the Medina Embolization Device when used in unruptured and ruptured intracranial aneurysms.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject has provided written informed consent using the Ethics Committee-approved consent form and agrees to comply with protocol requirements
  • Subject is 18- 85 years old
  • Subject has a ruptured or unruptured saccular intra-cranial aneurysm amenable to be treated with the Medina Embolization Device

排除标准

  • Aneurysm is partially thrombosed
  • Aneurysm has been previously treated with surgery or endovascular therapy
  • Subject has had major brain surgery including endovascular procedures within the past 30 days
  • Vessel characteristics (tortuosity, stenosis, morphology) preclude safe endovascular access to the aneurysm
  • Subject is pregnant or breast-feeding or wishes to become pregnant during the length of the study participation
  • The Investigator determines that the validity of the study outcomes may be compromised by the subject's enrollment

结局指标

主要结局

Complete aneurysm occlusion as defined by the Modified Raymond-Roy Classification (MRRC)

时间窗: 12 months

次要结局

未报告次要终点

研究者

发起方
Medtronic Neurovascular Clinical Affairs
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验

Medina Embolization Device In Neurovascular Aneurysm... | 临床试验